3,3'-diiodo-L-thyronine
Modify Date: 2024-01-08 15:08:49
3,3'-diiodo-L-thyronine structure
|
Common Name | 3,3'-diiodo-L-thyronine | ||
|---|---|---|---|---|
| CAS Number | 4604-41-5 | Molecular Weight | 525.077 | |
| Density | 2.1±0.1 g/cm3 | Boiling Point | 520.7±50.0 °C at 760 mmHg | |
| Molecular Formula | C15H13I2NO4 | Melting Point | 178-180ºC | |
| MSDS | USA | Flash Point | 268.7±30.1 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
Use of 3,3'-diiodo-L-thyronine3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity[1][2]. |
| Name | 3,3'-diiodo-L-thyronine |
|---|---|
| Synonym | More Synonyms |
| Description | 3,3'-Diiodo-L-thyronine (3,3'-T2) is an endogenous metabolite of thyroid hormone. 3,3'-Diiodo-L-thyronine significantly enhances COX activity[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Human Endogenous Metabolite COX |
| In Vitro | 3,3'-Diiodo-L-thyronine (3,3'-T2; 1 μM; 30 min) significantly enhances COX activity[2]. 3,3'-Diiodo-L-thyronine of 1 μM has the maximum effect[2]. 3,3'-Diiodo-L-thyronine is produced by further degradation of T3 and rT3[3]. |
| References |
| Density | 2.1±0.1 g/cm3 |
|---|---|
| Boiling Point | 520.7±50.0 °C at 760 mmHg |
| Melting Point | 178-180ºC |
| Molecular Formula | C15H13I2NO4 |
| Molecular Weight | 525.077 |
| Flash Point | 268.7±30.1 °C |
| Exact Mass | 524.893372 |
| PSA | 92.78000 |
| LogP | 4.55 |
| Vapour Pressure | 0.0±1.4 mmHg at 25°C |
| Index of Refraction | 1.726 |
| Storage condition | Amber Vial, -20°C Freezer, Under Inert Atmosphere |
|
Redesigned Escherichia coli cytosine deaminase: a new facet of suicide gene therapy.
J. Gene Med. 17 , 132-9, (2015) The Escherichia coli cytosine deaminase (CD)/5-fluorocytosine (5-FC) approach emerges as a potential aid for suicide gene therapy in the field of modern cancer treatment. However, the poor binding aff... |
|
|
Axial T1ρ MRI as a diagnostic imaging modality to quantify proteoglycan concentration in degenerative disc disease.
Eur. Spine J. 24 , 2395-401, (2015) The aim of the study was to investigate if axial T1ρ MR images had similar accuracy as established sagittal T1ρ MRI for the assessment of proteoglycan concentration and content in intervertebral degen... |
|
|
Spider wrapping silk fibre architecture arising from its modular soluble protein precursor.
Sci. Rep. 5 , 11502, (2015) Spiders store spidroins in their silk glands as high concentration aqueous solutions, spinning these dopes into fibres with outstanding mechanical properties. Aciniform (or wrapping) silk is the tough... |
| 3,3’-Diiodo-L-thyronine |
| O-(4-Hydroxy-3-iodophenyl)-3-iodo-L-tyrosine |
| 3,3'-Diiodo-L-thyronine |
| L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3-iodo- |
| EINECS 225-005-7 |